rs56270341

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2

The NM_002578.5(PAK3):​c.531G>A​(p.Glu177Glu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00327 in 1,201,610 control chromosomes in the GnomAD database, including 6 homozygotes. There are 1,172 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0024 ( 0 hom., 70 hem., cov: 23)
Exomes 𝑓: 0.0034 ( 6 hom. 1102 hem. )

Consequence

PAK3
NM_002578.5 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.612

Publications

2 publications found
Variant links:
Genes affected
PAK3 (HGNC:8592): (p21 (RAC1) activated kinase 3) The protein encoded by this gene is a serine-threonine kinase and forms an activated complex with GTP-bound RAS-like (P21), CDC2 and RAC1. This protein may be necessary for dendritic development and for the rapid cytoskeletal reorganization in dendritic spines associated with synaptic plasticity. Defects in this gene are the cause of a non-syndromic form of X-linked intellectual disability. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2017]
PAK3 Gene-Disease associations (from GenCC):
  • corpus callosum, agenesis of
    Inheritance: XL Classification: DEFINITIVE Submitted by: G2P
  • intellectual disability, X-linked 30
    Inheritance: XL Classification: DEFINITIVE, STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • X-linked syndromic intellectual disability
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • non-syndromic X-linked intellectual disability
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.51).
BP6
Variant X-111162977-G-A is Benign according to our data. Variant chrX-111162977-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 211837.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.612 with no splicing effect.
BS2
High Hemizygotes in GnomAd4 at 70 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PAK3NM_002578.5 linkc.531G>A p.Glu177Glu synonymous_variant Exon 9 of 18 ENST00000372007.10 NP_002569.1 O75914-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PAK3ENST00000372007.10 linkc.531G>A p.Glu177Glu synonymous_variant Exon 9 of 18 1 NM_002578.5 ENSP00000361077.4 O75914-2

Frequencies

GnomAD3 genomes
AF:
0.00237
AC:
263
AN:
110903
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.000425
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00152
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000764
Gnomad FIN
AF:
0.00302
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00426
Gnomad OTH
AF:
0.000676
GnomAD2 exomes
AF:
0.00237
AC:
428
AN:
180542
AF XY:
0.00228
show subpopulations
Gnomad AFR exome
AF:
0.000609
Gnomad AMR exome
AF:
0.000256
Gnomad ASJ exome
AF:
0.00107
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00238
Gnomad NFE exome
AF:
0.00401
Gnomad OTH exome
AF:
0.00289
GnomAD4 exome
AF:
0.00336
AC:
3667
AN:
1090656
Hom.:
6
Cov.:
28
AF XY:
0.00309
AC XY:
1102
AN XY:
356658
show subpopulations
African (AFR)
AF:
0.000495
AC:
13
AN:
26248
American (AMR)
AF:
0.000256
AC:
9
AN:
35174
Ashkenazi Jewish (ASJ)
AF:
0.00114
AC:
22
AN:
19322
East Asian (EAS)
AF:
0.0000332
AC:
1
AN:
30162
South Asian (SAS)
AF:
0.00196
AC:
106
AN:
53957
European-Finnish (FIN)
AF:
0.00220
AC:
89
AN:
40517
Middle Eastern (MID)
AF:
0.00122
AC:
5
AN:
4112
European-Non Finnish (NFE)
AF:
0.00394
AC:
3289
AN:
835312
Other (OTH)
AF:
0.00290
AC:
133
AN:
45852
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
120
239
359
478
598
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
124
248
372
496
620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00237
AC:
263
AN:
110954
Hom.:
0
Cov.:
23
AF XY:
0.00210
AC XY:
70
AN XY:
33270
show subpopulations
African (AFR)
AF:
0.000424
AC:
13
AN:
30633
American (AMR)
AF:
0.00
AC:
0
AN:
10359
Ashkenazi Jewish (ASJ)
AF:
0.00152
AC:
4
AN:
2635
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3518
South Asian (SAS)
AF:
0.000766
AC:
2
AN:
2611
European-Finnish (FIN)
AF:
0.00302
AC:
18
AN:
5963
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
218
European-Non Finnish (NFE)
AF:
0.00426
AC:
225
AN:
52835
Other (OTH)
AF:
0.000668
AC:
1
AN:
1498
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
11
21
32
42
53
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00206
Hom.:
25
Bravo
AF:
0.00211

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Nov 16, 2017
Athena Diagnostics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 27, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Jul 06, 2017
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Intellectual disability, X-linked 30 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

History of neurodevelopmental disorder Benign:1
Jul 28, 2016
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.51
CADD
Benign
1.5
DANN
Benign
0.47
PhyloP100
-0.61
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs56270341; hg19: chrX-110406205; API